Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Sensitization of Human Carcinoma Cells to Alkylating Agents by Small Interfering RNA Suppression of 3-Alkyladenine-DNA Glycosylase
2005 StandoutNobel
Human NK Cells Are Alerted to Induction of p53 in Cancer Cells by Upregulation of the NKG2D Ligands ULBP1 and ULBP2
2011
Genetic and Functional Studies Implicate HIF1 α as a 14q Kidney Cancer Suppressor Gene
2011 StandoutNobel
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Label-free Quantitative Proteomics and N-Glycoproteomics Analysis of KRAS-activated Human Bronchial Epithelial Cells
2012
Hepatocellular carcinoma
2003 Standout
Dysregulation of growth factor signaling in human hepatocellular carcinoma
2006
Molecular pathogenesis of human hepatocellular carcinoma
2002
Regulation of immune cell function and differentiation by the NKG2D receptor
2011
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Convergence of Mutation and Epigenetic Alterations Identifies Common Genes in Cancer That Predict for Poor Prognosis
2008
Assessment of Cisplatin-Induced Nephrotoxicity by Microarray Technology
2001 Standout
RAS oncogenes: weaving a tumorigenic web
2011
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
The Fos family of transcription factors and their role in tumourigenesis
2005
GSVA: gene set variation analysis for microarray and RNA-Seq data
2013 Standout
Telomeres and telomerase: A dual role in hepatocarcinogenesis
2004
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
2005 StandoutNature
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
2011 StandoutNature
A meta-analysis of the impact of short-term sleep deprivation on cognitive variables.
2010 Standout
Ras proteins: paradigms for compartmentalised and isoform-specific signalling
2007
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
MAP kinase signalling pathways in cancer
2007 Standout
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations
2008 StandoutNobel
EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells
2008
Role of nucleotide- and base-excision repair in genotoxin-induced neuronal cell death
2004
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
2007 StandoutNature
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
2007 Standout
Generation and Analysis of Genetically Defined Liver Carcinomas Derived from Bipotential Liver Progenitors
2005
Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis
2018 StandoutNobel
The essence of senescence: Figure 1.
2010 Standout
The transcriptional signature of dioxin in human hepatoma HepG2 cells
2000
U1 snRNP regulates cancer cell migration and invasion in vitro
2020 Standout
An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis
2004
The VHL/HIF axis in clear cell renal carcinoma
2012 StandoutNobel
DNA Repair Pathways and Cancer Prevention
1999
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
2007 StandoutNobel
Genetic mechanisms of hepatocarcinogenesis
2002
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
LOT1 (ZAC1/PLAGL1) and its family members: Mechanisms and functions
2006
Role of Free Radicals in the Neurodegenerative Diseases
2001 Standout
IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence
2010
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma†‡
2008
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Organ‐specific profiles of genetic changes in cancers caused by activation‐induced cytidine deaminase expression
2008 StandoutNobel
Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer
2009 Standout
A Conditional Mouse Model of Synovial Sarcoma: Insights into a Myogenic Origin
2007 StandoutNobel
Treatment of HCV Infection by Targeting MicroRNA
2013 Standout
Glycoproteomics
2022 StandoutNobel
Molecular Profiling of Human Hepatocellular Carcinoma Defines Mutually Exclusive Interferon Regulation and Insulin-Like Growth Factor II Overexpression
2004
Click-Chemistry Based High Throughput Screening Platform for Modulators of Ras Palmitoylation
2017 StandoutNobel
A Comprehensive Survey of Ras Mutations in Cancer
2012 Standout
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Overexpression and Amplification of Aurora-A in Hepatocellular Carcinoma
2004
Altered Detoxification Status and Increased Resistance to Oxidative Stress by K-Ras Transformation
2008
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
2014 Standout
Oncogenic K-RAS Is Required to Maintain Changes in Cytoskeletal Organization, Adhesion, and Motility in Colon Cancer Cells
2005
Works of Per Lund being referenced
Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis
2001
Insulin‐like growth factor binding protein‐related protein 1 (IGFBP‐rP1) has potential tumour‐suppressive activity in human lung cancer
2007
Down‐regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells
2009
Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells
2004
Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II
2003
Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation
2006
Transgenic systems in studies on genotoxicity of alkylating agents: critical lesions, thresholds and defense mechanisms
1998